Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B
Patricia Gita Naully; Marselina Irasonia Tan; Agustiningsih Agustiningsih; Caecilia Sukowati; Ernawati Arifin Giri-Rachman;
10.1016/j.aohep.2024.101533
A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues
Yan Gu; Yao Zhang; Zhiyi Zhang; Jian Wang; Qing Zhang; Shaoqiu Zhang; Yilin Liu; Jiacheng Liu; Juan Xia; Xiaomin Yan; Jie Li; Xingxiang Liu; Rui Huang; Chao Wu;
Ann Hepatol. 2024;29:
NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study
Renling Yao; Sufang Lu; Ruifei Xue; Jian Wang; Yuanwang Qiu; Yuxin Chen; Jiacheng Liu; Li Zhu; Jie Zhan; Suling Jiang; Shengxia Yin; Xin Tong; Weimao Ding; Jie Li; Chuanwu Zhu; Rui Huang; Chao Wu;
Ann Hepatol. 2024;29: